<DOC>
	<DOCNO>NCT00324350</DOCNO>
	<brief_summary>The purpose ACCORD-BONE Study investigate effect intensive glycemic control type 2 diabetes ( ACCORD participant ) factor relate bone health , include , fracture , fall , bone mineral density .</brief_summary>
	<brief_title>Intensive Glycemic Control Skeletal Health Study</brief_title>
	<detailed_description>Recent study establish type 2 diabetes risk factor fracture , particularly hip , shoulder foot . Additionally , type 2 diabetes associate 50-60 % increase risk fall . The high risk fracture associate type 2 diabetes important health burden patient . More frequent fall perhaps reduce bone strength diabetes think key contribute factor . The best approach prevent fracture type 2 diabetes yet understood . There observational evidence support hypothesis well glycemic control preserve bone reduce fall fracture . The ACCORD-BONE study provide unique opportunity determine whether intensive glycemic control prevent fracture , fall , bone loss older diabetic adult , may lead improved treatment prevention future .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Hypoglycemic Agents</mesh_term>
	<mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
	<criteria>Inclusion criterion : Fulfills criterion inclusion ACCORD main trial Must randomize ACCORD study participant five CCNs ACCORDBONE ancillary study . Exclusion criterion : Fulfills criterion exclusion ACCORD main trial</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Fracture</keyword>
	<keyword>Falls</keyword>
	<keyword>Height Loss</keyword>
</DOC>